/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR
DISSEMINATION IN THE UNITED
VANCOUVER, BC, April 26, 2021 /CNW/ - Numinus Wellness Inc.
("Numinus" or the "Company") (TSXV: NUMI), a mental
health care company advancing innovative treatments and safe,
evidence-based psychedelic-assisted therapies, is pleased to
announce that the TSX Venture Exchange ("TSXV") has accepted
for listing the 16,100,000 common share purchase warrants (the
"Warrants") issued pursuant to the Company's previously
announced prospectus offering that closed on March 19, 2021.
The Warrants will be listed for trading on the TSXV under the
symbol "NUMI.WT.C" effective at market open on Tuesday, April 27, 2021.
Each Warrant entitles the holder thereof to acquire one common
share of the Company at an exercise price of $1.75 until March 19,
2023. The Warrants were issued pursuant to, and are governed
by, the terms of a warrant indenture dated March 19, 2021 (the "Warrant Indenture")
between the Company and Odyssey Trust Company. A copy of the
Warrant Indenture is available under the Company's SEDAR profile at
In addition, the Company announces that the trading symbol for
its previously listed common share purchase warrants trading under
the symbol "NUMI.WS" will change to "NUMI.WT.B" effective at market
open on Monday, April 26, 2021.
Numinus Wellness (TSX-V; NUMI) empowers people to heal and be
well through the development and delivery of innovative mental
health care and access to safe, evidence-based psychedelic-assisted
therapies. The Numinus Wellness model - including psychedelic
production, supply, research and clinic care - is at the forefront
of a transformation aimed at healing rather than managing symptoms
for depression, anxiety, trauma, pain and substance abuse. At
Numinus, we are leading the integration of psychedelic-assisted
therapies into mainstream clinical practice, and building the
foundation for a healthier society.
Learn more at numinus.ca, and follow us on Facebook, Twitter,
This news release contains "forward-looking information"
within the meaning of applicable securities laws, including but not
limited to statements relating to the use of proceeds from the
Offering. Although the Company believes, in light of the experience
of its officers and directors, current conditions and expected
future developments and other factors that have been considered
appropriate, that the expectations reflected in this
forward-looking information are reasonable, undue reliance should
not be placed on them because the Company can give no assurance
that they will prove to be correct. Actual results and developments
may differ materially from those contemplated by these statements.
The statements in this press release are made as of the date of
this release and the Company assumes no responsibility to update
them or revise them to reflect new events or circumstances other
than as required by applicable securities laws. The Company
undertakes no obligation to comment on analyses, expectations or
statements made by third-parties in respect of the Company, its
subsidiaries, their securities, or their respective financial or
operating results (as applicable).
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
ON BEHALF OF THE BOARD OF NUMINUS WELLNESS INC.
President, Chief Executive Officer and Chair
SOURCE Numinus Wellness Inc.